Sign in to view content

Adjunctive Focal Laser Following Central Fluid Resolution After Bevacizumab, Ranibizumab, or Aflibercept Injection: A Secondary Analysis of Protocol T

Jennifer R Gallagher, MD

Video
Published 2020

Related

Treatment of Moderately Severe to Severe Nonproliferative Diabetic Retinopathy With Intravitreal Aflibercept Injection: 52-Week Results From PANORAMA
W. Lloyd Clark, MD, FASRS
Annual Meeting Talks
2019
Episode 5: Adding Dexamethasone Implant to Ranibizumab for Persistent DME with Dr. Raj Maturi
Keyvan Koushan, MD, FRCSC
Member Podcasts
2017
The Translation of CST to Visual Function: Persistent DME and QOL Measures With FAc Implants in the FAME Study
Michael A. Singer, MD
Annual Meeting Talks
2018

Category: Diabetic Retinopathy

See more